GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Valbiotis SA (FRA:8JD) » Definitions » EV-to-EBIT

Valbiotis (FRA:8JD) EV-to-EBIT : -2.32 (As of Jun. 05, 2024)


View and export this data going back to 2021. Start your Free Trial

What is Valbiotis EV-to-EBIT?

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Valbiotis's Enterprise Value is €16.57 Mil. Valbiotis's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was €-7.15 Mil. Therefore, Valbiotis's EV-to-EBIT for today is -2.32.

The historical rank and industry rank for Valbiotis's EV-to-EBIT or its related term are showing as below:

FRA:8JD' s EV-to-EBIT Range Over the Past 10 Years
Min: -15.27   Med: -3.76   Max: -0.61
Current: -2.32

During the past 9 years, the highest EV-to-EBIT of Valbiotis was -0.61. The lowest was -15.27. And the median was -3.76.

FRA:8JD's EV-to-EBIT is ranked worse than
100% of 425 companies
in the Biotechnology industry
Industry Median: 9.61 vs FRA:8JD: -2.32

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %. Valbiotis's Enterprise Value for the quarter that ended in Dec. 2023 was €53.16 Mil. Valbiotis's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was €-7.15 Mil. Valbiotis's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2023 was -13.44%.


Valbiotis EV-to-EBIT Historical Data

The historical data trend for Valbiotis's EV-to-EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Valbiotis EV-to-EBIT Chart

Valbiotis Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-EBIT
Get a 7-Day Free Trial Premium Member Only -2.50 -11.45 -6.19 -2.57 -8.50

Valbiotis Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
EV-to-EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -6.19 - -2.57 - -8.50

Competitive Comparison of Valbiotis's EV-to-EBIT

For the Biotechnology subindustry, Valbiotis's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Valbiotis's EV-to-EBIT Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Valbiotis's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Valbiotis's EV-to-EBIT falls into.



Valbiotis EV-to-EBIT Calculation

Valbiotis's EV-to-EBIT for today is calculated as:

EV-to-EBIT=Enterprise Value (Today)/EBIT (TTM)
=16.572/-7.147
=-2.32

Valbiotis's current Enterprise Value is €16.57 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Valbiotis's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was €-7.15 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Valbiotis  (FRA:8JD) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

Valbiotis's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2023 is calculated as:

Earnings Yield (Joel Greenblatt) % (Q: Dec. 2023 ) =EBIT / Enterprise Value (Q: Dec. 2023 )
=-7.147/53.158316
=-13.44 %

Valbiotis's Enterprise Value for the quarter that ended in Dec. 2023 was €53.16 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Valbiotis's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was €-7.15 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Valbiotis EV-to-EBIT Related Terms

Thank you for viewing the detailed overview of Valbiotis's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.


Valbiotis (FRA:8JD) Business Description

Traded in Other Exchanges
Address
12F rue Paul VATINE, Perigny, La Rochelle, FRA, 17180
Valbiotis SA is a research & development company. It is engaged in scientific innovation for preventing and combating metabolic diseases. Valbiotis has adopted an approach, aiming to revolutionize healthcare by developing a new class of Nutrition Health products designed to reduce the risk of major metabolic diseases, based on a multi-target approach by the use of plant-based ingredients.

Valbiotis (FRA:8JD) Headlines

No Headlines